Why would a surgeon hold warfarin (Coumadin) for two days after left femoral hemiarthroplasty in a patient with atrial fibrillation and a mechanical heart valve who currently has a therapeutic international normalized ratio, given that the target INR range is 2.5–3.5?

The surgeon is holding warfarin because the INR of 3.1 is above the safe threshold for major orthopedic surgery, which carries high bleeding risk

You are correct that the goal INR for a patient with both atrial fibrillation and a mechanical valve is typically 2.5-3.5 (depending on valve type and position), but this therapeutic target applies to chronic anticoagulation management, not perioperative management. The surgeon's plan to hold warfarin temporarily is appropriate given the high bleeding risk of hip surgery, even though this patient is at high thromboembolic risk.

Why the Warfarin is Being Held

For high-risk orthopedic procedures like hemiarthroplasty, surgery should proceed when INR <1.5 for low bleeding risk procedures, or ideally <1.2 for intermediate-to-high bleeding risk procedures 1. Hip surgery is considered high bleeding risk, and an INR of 3.1 significantly increases hemorrhagic complications during and after the procedure.

The ACC/AHA guidelines specifically address this scenario: patients with mechanical valves requiring noncardiac surgery are classified as "high risk of thrombosis" (which includes any mechanical mitral valve replacement OR any mechanical aortic valve with risk factors like atrial fibrillation) 2.

The Correct Perioperative Management

For this high-risk patient, the guidelines recommend:

• Warfarin should be stopped 48-72 hours before the procedure to allow INR to fall below 2.0 2
• Therapeutic doses of intravenous unfractionated heparin (UFH) should be started when the INR falls below 2.0 (typically 48h before surgery) 2
• UFH should be stopped 4-6 hours before the procedure 2
• UFH should be restarted as early after surgery as bleeding stability allows 2
• Continue UFH until the INR is again therapeutic with warfarin therapy 2

The Problem With the Surgeon's Plan

The surgeon's plan has a critical gap: simply holding warfarin for 2 days without bridging anticoagulation is inadequate and dangerous for this patient. This patient has BOTH a mechanical valve AND atrial fibrillation, placing them at very high risk for thromboembolism.

The Canadian guidelines explicitly state that bridging therapy with LMWH or UFH should be instituted when the INR falls below the therapeutic target in patients at high risk of thromboembolic events, specifically including those with mechanical heart valves 1.

What Should Actually Happen

1. Hold warfarin now (appropriate)
2. Start therapeutic UFH when INR drops below 2.0 (missing from current plan)
3. Stop UFH 4-6 hours before surgery
4. Restart UFH postoperatively once hemostasis is secure (typically 48-72 hours after high bleeding risk surgery) 1
5. Restart warfarin 24-72 hours postoperatively (the 2mg dose mentioned seems reasonable as a restart dose)
6. Continue UFH until INR is therapeutic (≥2.0 for two consecutive days) 3

Target INR After Surgery

Yes, the goal INR is 2.5-3.5 for mechanical mitral valves, or 2.5-3.5 for mechanical aortic valves with risk factors like atrial fibrillation 2, 4, 3. The specific target depends on:

• Mechanical mitral valve: INR 2.5-3.5 2, 3
• Mechanical aortic valve with atrial fibrillation: INR 2.5-3.5 2, 4
• Bileaflet mechanical aortic valve without risk factors: INR 2.0-3.0 2, 4, 3

Critical Action Needed

Contact the surgical team immediately to discuss bridging anticoagulation. The current plan exposes this patient to unacceptable thrombotic risk during the perioperative period. The absence of bridging therapy contradicts Class I recommendations for high-risk patients with mechanical valves 2.